BrosMed Medical Achieves CE Certification for Mars and Mars NC PTCA Balloon Dilatation Catheters Under EU MDR Regulations
Sept. 30th, 2024 – BROSMED, an industry-leading multinational group in the field of intravascular interventional medical devices, is thrilled to announce that they have successfully obtained CE certification for next-generation Mars and Mars NC PTCA balloon dilatation catheters under EU MDR regulations.
The Mars SC PTCA balloon dilatation catheter offers superior crossability and deliverability through tight and tortuous lesions. Mars SC includes 1.0 and 1.25mm diameter options that feature an ultra-low 0.016’’ tip entry profile to specifically address the challenging CTOs. Patented balloon forming and folding technology significantly reduces the thickness of the balloon layer, enhances the crossability and re-wrapping ability, and therefore provides exceptional flexibility and trackability. Also, by applying patented Pole-Vault processing technology, the optimal shaft design offers excellent kink resistance and pushability performance.
The Mars NC PTCA balloon dilatation catheter employs innovative double-layer Nylon and Pebax balloon materials with a rigid exterior and a soft interior. This innovative balloon layer design provides high RBP up to 22 atm with minimal longitudinal elongation and facilitates excellent balloon flexibility and wrapping performance at the same time. The enhanced balloon-forming process optimizes high-pressure resistance and gains an edge in conquering calcified lesions. Furthermore, the Mars NC features a wider balloon diameter of up to 6.0mm to meet diverse clinical needs. Both Mars and Mars NC PTCA balloon dilatation catheter has an extended 145cm shaft length.
The Mars and Mars NC are built based on BrosMed Medical’s expertise in combining multiple innovative leading technologies. The launch of Mars and Mars NC on the market provides physicians with optimized tool options and better clinical outcomes.
About BrosMed
Specializing in the research, development, manufacturing, and global sales of interventional technologies and products for complex vascular diseases, BrosMed is the industry-leading multinational group in the field of intravascular interventional medical devices. We have over 40 product series and more than 520 product registration certificates worldwide. Our products cover cardiovascular intervention, peripheral intervention, vascular access, neurovascular intervention, and interventional accessories. Our products are marketed in over 100 countries and regions globally. BrosMed Medical adheres to the mission of “Technology Embraces Life,” actively practices a globalized integration of medical and engineering, and promotes an open innovation model of integrating industry, universities, and scientific research institutions. We are dedicated to continuously providing safe, effective, high-quality, and innovative intravascular interventional solutions for global experts and patients.
